Long-Term Efficacy and Safety of Pimecrolimus Cream 1% in Adults with Moderate Atopic Dermatitis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Dermatology 2004;208:365–372, ISSN: 1018-8665
- Ereignis
-
Veröffentlichung
- (wo)
-
Dresden
- (wer)
-
Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden
- (wann)
-
2014
- Urheber
-
Meurer, Michael
Fartasch, Manige
Albrecht, Gisela
Vogt, Thomas
Worm, Margitta
Ruzicka, Thomas
Altmeyer, Peter
Schneider, Dirk
Weidinger, Gottfried
Bräutigam, Matthias
- URN
-
urn:nbn:de:bsz:14-qucosa-135560
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:50 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Meurer, Michael
- Fartasch, Manige
- Albrecht, Gisela
- Vogt, Thomas
- Worm, Margitta
- Ruzicka, Thomas
- Altmeyer, Peter
- Schneider, Dirk
- Weidinger, Gottfried
- Bräutigam, Matthias
- Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden
Entstanden
- 2014
Ähnliche Objekte (12)
Efficacy of docosahexaenoic acid in patients with atopic dermatitis
Pimecrolimus Cream in the Long-Term Management of Atopic Dermatitis in Adults: A Six-Month Study
Update "Systemic treatment of atopic dermatitis" of the S2k‐guideline on atopic dermatitis
Essential aspects of atopic dermatitis
Study of the efficacy of a new topical skin formulation rich in antioxidants in patients with mild to moderate atopic dermatitis
High recurrence rate of eczema herpeticum in moderate/severe atopic dermatitis: TREATgermany registry analysis
Effect of abrocitinib on skin biomarkers in patients with moderate‐to‐severe atopic dermatitis
Atopic dermatitis : from pathognesis to treatment
Atopic dermatitis: a global health perspective
Lebrikizumab provides rapid response in EASI components and itch in moderate-to-severe atopic dermatitis
Current concepts in clinical management and long-term control of atopic dermatitis : focus on pimecrolimus cream 1% ; with 11 tables
Atopic skin diathesis rather than atopic dermatitis is associated with specific contact allergies
Efficacy of docosahexaenoic acid in patients with atopic dermatitis
Pimecrolimus Cream in the Long-Term Management of Atopic Dermatitis in Adults: A Six-Month Study
Update "Systemic treatment of atopic dermatitis" of the S2k‐guideline on atopic dermatitis
Essential aspects of atopic dermatitis
Study of the efficacy of a new topical skin formulation rich in antioxidants in patients with mild to moderate atopic dermatitis
High recurrence rate of eczema herpeticum in moderate/severe atopic dermatitis: TREATgermany registry analysis
Effect of abrocitinib on skin biomarkers in patients with moderate‐to‐severe atopic dermatitis
Atopic dermatitis : from pathognesis to treatment
Atopic dermatitis: a global health perspective
Lebrikizumab provides rapid response in EASI components and itch in moderate-to-severe atopic dermatitis
Current concepts in clinical management and long-term control of atopic dermatitis : focus on pimecrolimus cream 1% ; with 11 tables
Atopic skin diathesis rather than atopic dermatitis is associated with specific contact allergies
Efficacy of docosahexaenoic acid in patients with atopic dermatitis
Pimecrolimus Cream in the Long-Term Management of Atopic Dermatitis in Adults: A Six-Month Study
Update "Systemic treatment of atopic dermatitis" of the S2k‐guideline on atopic dermatitis
Essential aspects of atopic dermatitis
Study of the efficacy of a new topical skin formulation rich in antioxidants in patients with mild to moderate atopic dermatitis
High recurrence rate of eczema herpeticum in moderate/severe atopic dermatitis: TREATgermany registry analysis
Effect of abrocitinib on skin biomarkers in patients with moderate‐to‐severe atopic dermatitis
Atopic dermatitis : from pathognesis to treatment
Atopic dermatitis: a global health perspective
Lebrikizumab provides rapid response in EASI components and itch in moderate-to-severe atopic dermatitis
Current concepts in clinical management and long-term control of atopic dermatitis : focus on pimecrolimus cream 1% ; with 11 tables